Community/Retail

Pharmacy Times® interviewed Brady Stein, MD, MHSc, of the Feinberg School of Medicine at Northwestern University, on the issues existing around prior data on the causes of death for patients with polycythemia vera (PV) and why it was important to have greater clarity in this area.

Pharmacy Times® interviewed Charles Nakar, MD and Amy Shapiro, MD, of the Indiana Hemophilia & Thrombosis Center, on how airway obstruction and respiratory distress can impact pediatric patients versus adult patients.

Pharmacy Times® interviewed Charles Nakar, MD and Amy Shapiro, MD, of the Indiana Hemophilia & Thrombosis Center, on what the treatment options are for patients with congenital plasminogen deficiency with airway obstruction and respiratory distress.

Pharmacy Times® interviewed Christopher Moxham of Fulcrum Therapeutics, on what FTX-6058 is, how it was developed, and what it is able to treat.

Pharmacy Times® interviewed Christopher Moxham of Fulcrum Therapeutics, on how maintaining expression of the anti-sickling gamma ortholog could be beneficial for children and adults with sickle cell disease, and why this is important to investigate.

Pharmacy Times® interviewed Charles Nakar, MD and Amy Shapiro, MD, of the Indiana Hemophilia & Thrombosis Center, on the common manifestations of congenital plasminogen deficiency, and whether it is life threatening for patients.

Pharmacy Times® interviewed Brady Stein, MD, MHSc, of the Feinberg School of Medicine at Northwestern University, on the common treatments for patients with polycythemia vera.

Pharmacy Times® interviewed Brady Stein, MD, MHSc, of the Feinberg School of Medicine at Northwestern University, on the survival estimates for patients with polycythemia vera in the past and the mortality rates among these patients.

Pharmacy Times® interviewed Brady Stein, MD, MHSc, of the Feinberg School of Medicine at Northwestern University, on what polycythemia vera (PV) is and why it was important to understand mortality and causes of death among patients with PV.

Pharmacy Times® interviewed Christopher Moxham of Fulcrum Therapeutics, on what sickle cell disease and beta-thalassemias are caused by, and how hemoglobin gamma can prevent or reduce disease-related pathophysiology in these disorders.

A flu vaccine is especially important this year, as it can prevent a “twindemic” with COVID-19.

A recent nationwide survey of 400 pharmacists conducted by the American Pharmacists Association (APhA) found that more than three-fourths of pharmacists plan to be vaccinated with 1 of the coronavirus disease 2019 (COVID-19) vaccines.

Although most people say they will receive a COVID-19 vaccine once it becomes available, 27% were unsure.

Study indicates pure CBD was able to reduce cell viability in 3 of the 6 cell lines and that this effect was cell line specific rather than specific to certain cancers.

In recent years, digital health devices have offered pathways for patients to record and send data, which may ultimately encourage the patient to be more interactive in their disease management.

According to the survey results, 56% of patients with chronic obstructive pulmonary disease reported that COVID-19 has made it difficult for them to receive treatment

Proteases are important to the health and viability of cells and viruses. If proteases are inhibited, cells cannot perform many important functions, such as replication.

The treatment of mental illness has long been a quandary for medical professionals throughout history. But historically, mental illness has been more loosely defined than it is today.

Following authorization allowing pharmacists to administer childhood vaccines, some pediatricians have expressed concerns that this deprives children of medical care or could lead to missed vaccines.

The researchers launched the Perinatal Experiences and COVID-19 Effects Study to better understand the mental health and well-being of pregnant and postpartum individuals within the United States during the COVID-19 pandemic.

Despite the COVID-19 pandemic, several promising drugs are expected to hit the market in late 2020 and early 2021.

Glucose levels should be screened at herpes zoster diagnosis.

Beta-blockers could be used as a potential treatment for COVID-19, according to a study by Italian and Australian researchers.

Further, the findings suggest that cancer survivors are also likely to be at an increased risk of severe coronavirus disease 2019 (COVID-19) outcomes, given that both influenza and COVID-19 are both epidemic respiratory viruses.

Warning letters requested that companies immediately stop selling these unapproved products and said consumers concerned about COVID-19 should talk to their health care provider.

Xolair provides an alternative to surgery or steroids for the treatment of nasal polyps in adults.

Pharmacists must demonstrate value to achieve success when implementing new services and especially when establishing an entirely new practice.

The COVID-19 mRNA vaccine, BNT162b2, developed by Pfizer and BioNTech, has been granted a temporary authorization for emergency use against COVID-19 in the United Kingdom.

The connection between COVID-19 and sleep apnea cannot be explained by obesity rates alone.

In an interview with Pharmacy Times, Bruce Mueller, PharmD, interim dean and professor of clinical pharmacy at the University of Michigan College of Pharmacy, said pharmacists are essential in providing the correct dosing to patients with kidney disease.